top of page

Howard McLeod, PharmD, FASCO, FCCP

Medical Director for Precision Medicine, The Geriatric Oncology Consortium

Director, Center for Precision Medicine and Functional Genomics, Utah Tech University

Dr. Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. He is the Medical Director for Precision Medicine at the Geriatric Oncology Consortium and a Professor of Medicine and Biomedical Sciences at Utah Tech University.  Dr. McLeod is a recent member of both the FDA Committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Dr. McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy. He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies. Howard has published over 600 peer-reviewed papers on pharmacogenomics, precision medicine, applied therapeutics, or clinical pharmacology and continues to work to advance innovative healthcare. 

bottom of page